Skip to main content
. 2021 Mar 22;16(11):1697–1716. doi: 10.1002/cmdc.202100039

Figure 1.

Figure 1

Involvement of GPCRs and G proteins in human diseases and drug development. A) Distribution of approved drugs (small molecules and biologics) per human protein family class derived from Santos et al. [15] B) Putative primary Gα protein coupling, based on the classification of GPCR signaling according to Sriram et al. [5] C) Involvement of Gαi/s subfamilies in multiple disorders such as cancer, heart failure, endocrine disorders or thrombosis, adapted from Li et al. [1]